Inventor · disambiguated record
Carl R. Illig
Also filed as: ILLIG CARL · ILLIG CARL R
91 granted patents·2 pending applications·1,560 citations·filing 1989–2016
99Inventor score
Files withSTERLING WINTHROP INC37JANSSEN PHARMACEUTICA NV21DIMENSIONAL PHARM INC17ILLIG CARL R7EASTMAN KODAK CO3
Top patents by PatentIndex Score
93 records- 0198US5573749ANanoparticulate diagnostic mixed carboxylic anhydrides as X-ray contrast agents for blood pool and lymphatic system imagingNANO SYS LLC·Filed 1995·Granted Nov 12, 1996·126 cites·7 claims
- 0297US7645755B2Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Jan 12, 2010·45 cites·7 claims
- 0395US7973035B2Inhibitors of C-FMS kinaseJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Jul 5, 2011·24 cites·12 claims
- 0495US7414050B2Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Aug 19, 2008·36 cites·16 claims
- 0595US5466715A3,4-disubstituted phenols-immunomodulating agentsSTERLING WINTHROP INC·Filed 1994·Granted Nov 14, 1995·55 cites·12 claims
- 0694US9067898B1Isothiazole derivatives as GPR120 agonists for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jun 30, 2015·13 cites·20 claims
- 0793US7795279B2Method of inhibiting FLT3 kinaseJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Sep 14, 2010·30 cites·2 claims
- 0893US5643552ANanoparticulate diagnostic mixed carbonic anhydrides as x-ray contrast agents for blood pool and lymphatic system imagingNANOSYSTEMS LLC·Filed 1995·Granted Jul 1, 1997·152 cites·5 claims
- 0993US5525328ANanoparticulate diagnostic diatrizoxy ester X-ray contrast agents for blood pool and lymphatic system imagingNANOSYSTEMS LLC·Filed 1994·Granted Jun 11, 1996·157 cites·10 claims
- 1092US7662837B2Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Feb 16, 2010·26 cites·22 claims
- 1192US5472683ANanoparticulate diagnostic mixed carbamic anhydrides as X-ray contrast agents for blood pool and lymphatic system imagingEASTMAN KODAK CO·Filed 1995·Granted Dec 5, 1995·117 cites·10 claims
- 1290US6403633B2Heteroaryl amidines, methylamidines and guanidines, and use thereof as protease inhibitorsDIMENSIONAL PHARM INC·Filed 2001·Granted Jun 11, 2002·21 cites·108 claims
- 1388US5260478AIodinated aroyloxy carboxamidesSTERLING WINTHROP INC·Filed 1992·Granted Nov 9, 1993·29 cites·8 claims
- 1487US6562840B1Heteroaryl amidines, methylamidines and guanidines, and the use thereof as protease inhibitorsDIMENSIONAL PHARM INC·Filed 2002·Granted May 13, 2003·16 cites·36 claims
- 1586US6515002B2Compounds and compositions for treating C1s-mediated diseases and conditionsDIMENSIONAL PHARM INC·Filed 2001·Granted Feb 4, 2003·26 cites·13 claims
- 1685US8497376B2Inhibitors of c-fms kinaseILLIG CARL R·Filed 2008·Granted Jul 30, 2013·13 cites·16 claims
- 1784US9266866B2Inhibitors of C-FMS kinaseJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Feb 23, 2016·4 cites·9 claims
- 1884US8895584B2Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Nov 25, 2014·4 cites·16 claims
- 1984US8859602B2Inhibitors of c-fms kinaseILLIG CARL R·Filed 2007·Granted Oct 14, 2014·4 cites·11 claims
- 2084US8815867B2Inhibitors of c-fms kinaseILLIG CARL R·Filed 2007·Granted Aug 26, 2014·4 cites·9 claims
- 2183US7030112B2Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disordersBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Apr 18, 2006·21 cites·2 claims
- 2283US6492403B1Methods of treating C1s-mediated diseases and conditions and compositions thereofDIMENSIONAL PHARM INC·Filed 2000·Granted Dec 10, 2002·22 cites·27 claims
- 2382US9193736B2PDE 10a inhibitors for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Nov 24, 2015·7 cites·14 claims
- 2482US6706765B2Aminoguanidines and alkoxyguanidines as protease inhibitorsDIMENSIONAL PHARM INC·Filed 2003·Granted Mar 16, 2004·12 cites·34 claims
- 2582US5741819AArylsulfonylaminobenzene derivatives and the use thereof as factor Xa inhibitorsDIMENSIONAL PHARM INC·Filed 1995·Granted Apr 21, 1998·57 cites·27 claims
- 2681US6638931B1Aminoguanidines and alkoxyguanidines as protease inhibitorsDIMENSIONAL PHARM INC·Filed 2000·Granted Oct 28, 2003·11 cites·39 claims
- 2781US5792769AGuanidino protease inhibitors3-DIMENSIONAL PHARM INC·Filed 1996·Granted Aug 11, 1998·34 cites·49 claims
- 2880US8759347B2Inhibitors of C-FMS kinaseJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jun 24, 2014·3 cites·18 claims
- 2980US6730783B2Process for preparing aminoguanidines and alkoxyguanidines as protease inhibitorsDIMENSIONAL PHARM INC·Filed 2003·Granted May 4, 2004·9 cites·39 claims
- 3080US5330739AIodinated benzoyl acetals and ketals for x-ray imagingSTERLING WINTHROP INC·Filed 1992·Granted Jul 19, 1994·17 cites·7 claims
- 3179US9296726B2Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Mar 29, 2016·2 cites·7 claims
- 3279US8722718B2Inhibitors of C-FMS kinaseILLIG CARL R·Filed 2007·Granted May 13, 2014·2 cites·10 claims
- 3379US6518310B2Aminoguanidines and alkoxyguanidines as protease inhibitorsDIMENSIONAL PHARM INC·Filed 2001·Granted Feb 11, 2003·9 cites·36 claims
- 3479US6281206B1Amidino protease inhibitorsDIMENSIONAL PHARM INC·Filed 2000·Granted Aug 28, 2001·8 cites·28 claims
- 3578US5476644ACyclic triamine chelating agentsSTERLING WINTHROP INC·Filed 1994·Granted Dec 19, 1995·16 cites·23 claims
- 3677US8481564B2Inhibitors of c-fms kinaseILLIG CARL R·Filed 2011·Granted Jul 9, 2013·2 cites·19 claims
- 3776US9221797B2Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Dec 29, 2015·2 cites·18 claims
- 3876US7705042B2Class of arylamide compounds useful as inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Apr 27, 2010·3 cites·11 claims
- 3975US6291514B1Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitorsDIMENSIONAL PHARM INC·Filed 1999·Granted Sep 18, 2001·15 cites·60 claims
- 4075US5891909AAmidinohydrazones as protease inhibitorsDIMENSIONAL PHARM INC·Filed 1997·Granted Apr 6, 1999·39 cites·76 claims
- 4174US7326788B2Quinolinone derivatives as inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Feb 5, 2008·8 cites·6 claims
- 4274US6414020B2Amidino protease inhibitorsDIMENSIONAL PHARM INC·Filed 2001·Granted Jul 2, 2002·4 cites·27 claims
- 4373US6225302B1Amidino protease inhibitorsDIMENSIONAL PHARM INC·Filed 2000·Granted May 1, 2001·4 cites·26 claims
- 4473US5012000ATotal synthesis of chiral 2-amino-1,3-diolsEASTMAN KODAK CO·Filed 1989·Granted Apr 30, 1991·10 cites·3 claims
- 4569US5368837AX-ray contrast compositions containing an organic crystalline X-ray contrast agent and a cellulose derivativeSTERLING WINTHROP INC·Filed 1994·Granted Nov 29, 1994·36 cites·7 claims
- 4668US9526731B2Method of inhibiting C-KIT kinaseJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Dec 27, 2016·0 cites·1 claims
- 4768US8697716B2Method of inhibiting C-KIT kinaseILLIG CARL R·Filed 2007·Granted Apr 15, 2014·0 cites·2 claims
- 4868US5384107AIodinated aromatic compoundsSTERLING WINTHROP INC·Filed 1994·Granted Jan 24, 1995·9 cites·7 claims
- 4968US5068345AOxazolidinone aldol adductEASTMAN KODAK CO·Filed 1989·Granted Nov 26, 1991·7 cites·7 claims
- 5067US9403804B2Inhibitors of c-fms kinaseJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 2, 2016·0 cites·11 claims
Showing the top 50 of 93 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Carl R. Illig files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →